Bexsero vs Trumenba: How They Differ and What U.S. Patients Should Know

Bexsero and Trumenba are both licensed in the United States to prevent meningococcal serogroup B disease, and neither is clearly superior to the other. The practical difference that matters most is scheduling and brand consistency: for healthy adolescents and young adults, both now follow a two dose series given six months apart, and a series must be completed with the same manufacturer’s product from start to finish.

TL;DR:

• If dose two is given before month six, a third dose is required at least four months later and six months after the first dose.
• Higher risk people and those needing faster protection receive doses at months zero, one to two, and six; ongoing risk may require boosters.
• Routine vaccination is favored at ages 16 to 18; through age 23, healthy people can discuss vaccination with a clinician, especially if living in dorms.
• Never switch between Bexsero and Trumenba midseries because the products are not interchangeable; check records with the original provider before restarting an uncertain series.
• MenB vaccination is generally not required for immigration medical exams, but dated records help civil surgeons document vaccination history and prevent avoidable delays.

Table of Contents

• How Bexsero and Trumenba compare at a glance
• What the FDA and ACIP say about who should get vaccinated
• Exact dosing rules for the two-dose and three-dose series
• Safety profile and what reactions to expect
• Why you cannot mix Bexsero and Trumenba mid-series
• Who should prioritize vaccination and how to decide
• Getting vaccinated in the U.S. and what it means for your immigration exam
• Our take on choosing between the two vaccines
• How we can help with your immigration medical exam
• FAQ
• Sources

How Bexsero and Trumenba compare at a glance

Bexsero (MenB-4C) is made by GSK, and Trumenba (MenB-FHbp) is made by Pfizer. Both are licensed in the U.S. for people aged 10 to 25, with Trumenba approved in 2014 and Bexsero approved the following year for U.S. use.

For years, the two vaccines had different dosing intervals, which made side by side scheduling confusing. That changed in late 2024 when federal guidance aligned Bexsero’s standard interval with Trumenba’s, so both now use a two dose schedule at 0 and 6 months for most healthy recipients, with a three dose option for those who need faster or stronger protection.

• Manufacturer: Bexsero is made by GSK; Trumenba is made by Pfizer.
• Standard series: Both now use two doses, six months apart, for healthy adolescents and young adults.
• Accelerated series: A three dose schedule (0, 1 to 2, and 6 months) applies to people at increased risk or who need protection sooner.
• Recordkeeping tip: Write down the exact brand name at every visit. Mixing brands means the series does not count and must restart.

What the FDA and ACIP say about who should get vaccinated

Both products carry FDA licensure for ages 10 through 25, but routine use outside high-risk groups is governed by shared clinical decision-making rather than a blanket recommendation. That means a clinician and patient weigh individual circumstances, such as living in a college dorm or attending a school with recent cases, rather than following a universal mandate.

• Routine MenB vaccination is preferred for ages 16 to 18, the point at which short-term risk is highest for many young adults.
• Shared decision-making extends the option through age 23 for those who want protection but do not fall into a defined risk category.
• People with asplenia, complement deficiencies, or complement inhibitor use fall into a separate, higher-priority group with a firmer recommendation for vaccination.

Exact dosing rules for the two-dose and three-dose series

Scheduling precision matters because an early or mismatched dose can mean starting over. The rules below reflect the 2024 ACIP update that aligned Bexsero’s interval with Trumenba’s.

1. Standard two-dose series: Healthy adolescents and young adults receive dose one, then dose two at month 6.
2. Accelerated three-dose series: People at increased risk, or those needing faster protection, receive doses at 0, 1 to 2 months, and 6 months.
3. Early second dose: If the second dose is given less than 6 months after the first, a third dose is required, timed at least 4 months after dose two and at least 6 months after dose one.
4. Late second dose: A second dose given later than 6 months remains valid and does not need repeating.
5. Combination product consideration: Penbraya, a pentavalent vaccine containing the Trumenba MenB component alongside MenACWY protection, can complete part of the series when both vaccines are indicated at the same visit, but it ties any remaining MenB doses to the Trumenba brand.

Pro Tip: Ask your clinic to write the exact product name, not just “MenB vaccine,” on your immunization record every time you receive a dose.

Safety profile and what reactions to expect

Most people tolerate both vaccines well, with reactions that resemble other routine immunizations. Local pain and redness at the injection site are common, along with systemic symptoms like fever and muscle aches.

• Expect possible soreness, redness, or swelling where the shot was given.
• Fever, fatigue, headache, and muscle pain are the most frequently reported systemic reactions.
• Serious adverse events are uncommon, though no vaccine carries a zero-risk guarantee.
• Pregnancy is treated as a precaution: vaccination is typically deferred unless the person is at increased risk and has discussed the decision with a clinician.

The CDC’s Vaccine Information Statement for MenB vaccines notes that full protection requires completing the multi-dose series, and that the preferred age for short-term protection is 16 to 18. People who remain at ongoing increased risk, such as those with complement deficiencies, may need booster doses on a schedule their clinician sets based on continued exposure.

Why you cannot mix Bexsero and Trumenba mid-series

Bexsero and Trumenba target different antigens, which is why CDC guidance treats them as non-interchangeable. A dose of one brand does not substitute for a dose of the other, and a series started with one product has to finish with that same product.

• If your brand history is unknown or mixed, the safest path is to restart the primary series using a single, consistently available brand.
• Save every vaccine record that lists brand name, lot number, and date administered.
• When switching clinics or providers, bring your records so the new office can match your existing brand rather than guessing.

Pro Tip: If you’ve lost track of which brand you received, ask your original provider’s office for records before assuming you need to start over. Many clinics retain this information for years.

Who should prioritize vaccination and how to decide

People with asplenia, certain complement deficiencies, or those taking complement inhibitor medications face meaningfully higher risk from meningococcal B disease and are the clearest candidates for the three dose series. Microbiologists who routinely handle Neisseria meningitidis isolates and people exposed during a declared outbreak fall into the same higher-priority group.

• Discuss college dorm residence, recent campus outbreaks, or travel to high-risk settings with your clinician when deciding on shared decision-making vaccination.
• Ages 16 to 18 represent the window where routine vaccination is most strongly favored for healthy individuals.
• Anyone with ongoing elevated risk should ask their clinician about booster timing rather than assuming one series provides lifetime coverage.

Getting vaccinated in the U.S. and what it means for your immigration exam

MenB vaccines are available through primary care offices, many retail pharmacies, public health clinics, and college health centers across the country. Whichever location you choose, ask for a printed or electronic record noting the exact brand and date, since you will need that information if you continue the series elsewhere. Many health plans cover ACIP-recommended vaccines, though it is worth confirming coverage and any pharmacy billing codes in advance.

• MenB vaccination is not typically a required vaccine for Form I-693 status-adjustment purposes, since civil surgeons follow federal Technical Instructions that focus on other routine immunizations.
• A civil surgeon can still document your MenB history and advise on other recommended vaccines during your exam.
• Bringing complete, dated vaccine records to your immigration medical exam helps avoid delays caused by missing or unclear documentation.

Our take on choosing between the two vaccines

Either licensed MenB product works well when the series is completed correctly. The real decision points are timing and consistency: pick the three dose accelerated schedule if you need protection quickly or fall into a higher-risk group, and stick with one brand for every dose. Clear, dated vaccine records prevent the most common and avoidable problem: restarting a series that was actually already complete.

— ImmigrationMedicalExams Medical Team

How we can help with your immigration medical exam

We specialize exclusively in Form I-693 immigration medical exams, which means no primary care visits, no urgent care triage, just the civil surgeon exam, vaccine review, and documentation your green card or adjustment of status case requires. When your vaccination records show gaps, including unclear MenB history, we can review your records and advise on vaccination when appropriate.

• Our pricing approach is designed to minimize unexpected charges once your exam begins.
• Standard processing takes about 3 days, with a 2-day expedited option for applicants on a tighter deadline.
• Online scheduling is open 24/7, so you can book a visit whenever it fits your schedule.

We have extensive experience with immigration medical exams and often assist applicants who arrive with incomplete vaccination documentation or previous exam issues. Start with our USCIS immigration medical exam service page to see what your visit includes, or review pricing and add-on services if you need titer testing or additional vaccinations alongside your exam.

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

FAQ

What meningococcal vaccines are available in the US?

The United States licenses MenACWY vaccines for serogroups A, C, W, and Y, along with two MenB vaccines, Bexsero and Trumenba, that protect against serogroup B. A pentavalent option called Penbraya combines MenACWY protection with the Trumenba MenB component in a single licensed product.

What are the reasons why someone might avoid the MenACWY vaccine?

Reasons generally center on individual medical history rather than the vaccine’s category as a whole, such as a documented severe allergic reaction to a previous dose or its components. Anyone with concerns about a specific reaction should discuss their history directly with a clinician before deciding.

Which meningitis B vaccine is best?

Neither Bexsero nor Trumenba is established as more effective than the other for routine use. The more important factor is completing whichever series you start with the same manufacturer’s product and following the correct interval for your risk level.

What are the potential side effects of the meningococcal vaccine?

Common reactions include pain, redness, or swelling at the injection site, along with fever, fatigue, and muscle aches that typically resolve within a few days. Serious reactions are uncommon, and pregnant individuals are generally advised to defer vaccination unless they fall into a higher-risk category, per the CDC’s guidance for adults.

Does my immigration medical exam require the MenB vaccine?

MenB vaccination is generally not a required vaccine for Form I-693 purposes, since civil surgeons follow federal Technical Instructions focused on other immunizations. A civil surgeon can still review your MenB history and discuss other recommended vaccines during your immigration medical exam.